Press Releases

ABOH Announces Winner of $150,000 Lung Cancer Research Award

We are announcing our 2024 recipient of the Julie Swedberg YOLO Cancer Research Award of $150,000. This is a new research award named in honor of Julie Swedberg, who died from lung cancer in 2023 as a 48-year-old non-smoker. Jessica Konen, PhD, of Emory University Winship Cancer Institute, will receive this national award in recognition and support of her work entitled MiR-29 as a master regulator of anti-tumor immunity. The project focuses on defining a novel mechanism of resistance to immune checkpoint inhibitor treatments in lung cancer.

Unraveling the Mysteries of Protein Lipidation with Creative Proteomics

PathAI and Aster Insights Partner to Deliver Combined AI-Derived Structured Pathology and Multimodal Real-World Data Solutions

PathAI, a global leader in AI-powered pathology, and Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced a multi-year strategic partnership to develop curated multimodal datasets that pair PathAI’s PathExplore1 artificial intelligence (AI) tumor microenvironment (TME) quantification panel with Aster Insights’ Avatar clinical, molecular, and digital pathology imaging data. By combining their respective best-in-class platforms, PathAI and Aster Insights will be able to expedite the development of novel insights to accelerate the discovery and development of new treatments for patients with cancer.

Protheragen-ING Lab, a Trustworthy GLP Service Provider, Unveils Its Cutting-Edge Medical Device Services

CD Formulation Provides Genotoxic Impurity Testing Services to Detect and Evaluate the Potential of GIs for API and Drug Substances

John Potthoff Joins RQM+ as CEO

D'OXYVA Launches New At-Home Study to Connect More People With Revolutionary Medical Technology

D'OXYVA is thrilled to launch its nationwide at-home safety and efficacy study, open to participants across the U.S.

Greenphire Named 2024 “Best Overall Patient Engagement Service” by MedTech Breakthrough Awards

Biopharma PEG to Showcase Innovative PEG Derivatives at BIO 2024 in San Diego

Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.

Dr. Vince Clinical Research Appoints World-Renowned Drug Developer, Clinical Pharmacologist and Neuroscientist Dr. Sheldon Preskorn as Senior VP of Neuroscience

Dr. Vince Clinical Research (DVCR) today announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience.

Huateng Pharma Introduces Piroctone Olamine: A New Solution for Fungal Infections and Dandruff Control

Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).

Alfa Chemistry Debuts Shape Memory Alloys, Nitinol SMAs, and 3D Printing Alloys

Lindus Health Announces Cosmetics Clinical Trial with Acinonyx Bio to Evaluate an Alternative to Benzoyl Peroxide for Inflammatory Acne

https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime

MDClone Earns Fourth Consecutive "Best Healthcare Big Data Platform" Award from MedTech Breakthrough

https://www.prnewswire.com/news-releases/mdclone-earns-fourth-consecutive-best-healthcare-big-data-platform-award-from-medtech-breakthrough-302147956.html?tc=eml_cleartime

Prebiotic Fibre Supplement Significantly Reduces Risk of Developing Type 2 Diabetes, UK Study Finds

Today, The British Journal of Nutrition published a study that found the consumption of a daily prebiotic fibre supplement helped to improve insulin sensitivity and other important health markers in patients with pre-diabetes.

Inceptua Group Expands Early Access Program to Latin America

Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.

Launch of a mutant RNA T7 polymerase with highly reduced double-stranded RNA formation

Takara Bio announces the launch of PrimeCap™ T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development.

Icosagen and Lead Discovery Center Announce Collaboration to Discover Novel Monoclonal Antibodies

Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.

Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform

Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.